Hirotaka Nagasaka

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Venues

International journal of clinical oncology

IJU case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hirotaka Nagasaka, Takeshi Kishida, Taku Kouro, Yuka Igarashi, Shinichi Takebe, Shotaro Yamamoto, Takuya Kondo, Mitsuyuki Koizumi, Hideyuki Terao, Takahisa Suzuki, Noboru Nakaigawa, Hidetomo Himuro, Feifei Wei, Tetsuro Sasada
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. International journal of clinical oncology 29 (6) (2024)
Hirotaka Nagasaka, Takahisa Suzuki, Takuya Kondo, Mitsuyuki Koizumi, Hideyuki Terao, Yuko Murohashi, Yoichiro Okubo, Tomoyuki Yokose, Takeshi Kishida
Retroperitoneal Doege-Potter syndrome with intraoperative blood glucose monitoring. IJU case reports 7 (5) (2024)
Hirotaka Nagasaka, Takeshi Kishida, Taku Kouro, Yuka Igarashi, Shinichi Takebe, Shotaro Yamamoto, Takuya Kondo, Mitsuyuki Koizumi, Hideyuki Terao, Takahisa Suzuki, Noboru Nakaigawa, Hidetomo Himuro, Feifei Wei, Tetsuro Sasada
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. International journal of clinical oncology 29 (6) (2024)
Hirotaka Nagasaka, Takeshi Kishida, Taku Kouro, Yuka Igarashi, Shinichi Takebe, Shotaro Yamamoto, Takuya Kondo, Mitsuyuki Koizumi, Hideyuki Terao, Takahisa Suzuki, Noboru Nakaigawa, Hidetomo Himuro, Feifei Wei, Tetsuro Sasada
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. International journal of clinical oncology (2024)
Hirotaka Nagasaka, Takeshi Kishida, Taku Kouro, Yuka Igarashi, Shinichi Takebe, Shotaro Yamamoto, Takuya Kondo, Mitsuyuki Koizumi, Hideyuki Terao, Takahisa Suzuki, Noboru Nakaigawa, Hidetomo Himuro, Feifei Wei, Tetsuro Sasada
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. International journal of clinical oncology 29 (6) (2024)
Hirotaka Nagasaka, Takeshi Kishida, Taku Kouro, Yuka Igarashi, Shinichi Takebe, Shotaro Yamamoto, Takuya Kondo, Mitsuyuki Koizumi, Hideyuki Terao, Takahisa Suzuki, Noboru Nakaigawa, Hidetomo Himuro, Feifei Wei, Tetsuro Sasada
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. International journal of clinical oncology 29 (6) (2024)

Hirotaka Nagasaka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hirotaka Nagasaka